{"count":9,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/3e7c0c5d-8f6b-4b42-8d57-bfcf8defa710/","filing_uuid":"3e7c0c5d-8f6b-4b42-8d57-bfcf8defa710","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/3e7c0c5d-8f6b-4b42-8d57-bfcf8defa710/print/","filing_document_content_type":"text/html","income":"12000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Kenneth E Swab","dt_posted":"2026-04-20T14:43:49-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"301 South Bronough Street","registrant_address_2":"Suite 600","registrant_different_address":false,"registrant_city":"Tallahassee","registrant_state":"FL","registrant_zip":"32301","registrant":{"id":401053970,"url":"https://lda.gov/api/v1/registrants/401053970/","house_registrant_id":null,"name":"GRAYROBINSON PA","description":"Law firm.","address_1":"301 South Bronough Street","address_2":"Suite 600","address_3":null,"address_4":null,"city":"Tallahassee","state":"FL","state_display":"Florida","zip":"32301","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KENNETH SWAB","contact_telephone":"+1 202-546-1761","dt_updated":"2026-07-28T11:59:14.995253-04:00"},"client":{"id":197355,"url":"https://lda.gov/api/v1/clients/197355/","client_id":75,"name":"ANGEL CAPITAL ASSOCIATION","general_description":"Private investor and angel group trade association.","client_government_entity":false,"client_self_select":null,"state":"KS","state_display":"Kansas","country":"US","country_display":"United States of America","ppb_state":"KS","ppb_state_display":"Kansas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-02-01"},"lobbying_activities":[{"general_issue_code":"FIN","general_issue_code_display":"Financial Institutions/Investments/Securities","description":"Implementation of SEC's expanded accredited investor definition. H.R.3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025 (INVEST Act), all provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71392,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"MCCANNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":94084,"prefix":null,"prefix_display":null,"first_name":"BLAIR","nickname":null,"middle_name":null,"last_name":"HANCOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":88,"name":"Securities & Exchange Commission (SEC)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Promotion of angel investment tax credits and exemptions. Promotion of public policy promoting angel capital investments. Implementation of Opportunity Zones. Issues related to carried interest. Issues related to IRC section 1202, Small Business Stock Gains Exclusion. S. 695, Small Business Investment Act of 2025, all provisions. H.R. 1199, Small Business Investment Act of 2025, all provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71392,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"MCCANNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":94084,"prefix":null,"prefix_display":null,"first_name":"BLAIR","nickname":null,"middle_name":null,"last_name":"HANCOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":88,"name":"Securities & Exchange Commission (SEC)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/673d4471-decf-4b13-aecd-f56014c37377/","filing_uuid":"673d4471-decf-4b13-aecd-f56014c37377","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/673d4471-decf-4b13-aecd-f56014c37377/print/","filing_document_content_type":"text/html","income":null,"expenses":"490000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Robert Egge","dt_posted":"2026-04-20T15:47:03-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th Street, NW","registrant_address_2":"Suite 500","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":1262,"url":"https://lda.gov/api/v1/registrants/1262/","house_registrant_id":30526,"name":"ALZHEIMER'S ASSOCIATION","description":null,"address_1":"655 15th Street, NW","address_2":"Suite 500","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROBERT EGGE","contact_telephone":"+1 202-638-8660","dt_updated":"2026-07-30T10:03:36.870640-04:00"},"client":{"id":102599,"url":"https://lda.gov/api/v1/clients/102599/","client_id":12,"name":"ALZHEIMER'S ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"NAPA Reauthorization Act (P.L. 118-92) Alzheimers Accountability and Investment Act (P.L. 118-93) Comprehensive Care for Alzheimers Act (S. 626 / H.R. 1637 118th Congress) Reauthorization of the BOLD Infrastructure for Alzheimer's Act (P.L. 115-406) BOLD Reauthorization Act (P.L. 118-142) Accelerating Access to Dementia & Alzheimers Provider Training (AADAPT) Act (H.R. 3747 / S. 4036) The Senator Elizabeth Dole 21st Century Veterans Healthcare and Benefits Improvement Act (P.L. 118-210) VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act of 2023 (S. 10 118th Congress) Access to Innovative Treatments Act of 2023 (H.R. 2408 118th Congress) Mandating Exclusive Review of Individual Treatments (MERIT) Act of 2023 (H.R. 133 118th Congress) Elder Justice Reauthorization and Modernization Act of 2023 (S. 1198/H.R. 2718 118th Congress) Expanding Veterans Options for Long-Term Care Act (S. 495/H.R.1815 118th Congress) Palliative Care and Hospice Education and Training Act (S. 2287/H.R. 4425 119th Congress) Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 (S. 1544/H.R. 1199 118th Congress) Supporting Our Seniors Act (S. 2584 118th Congress) Alleviating Barriers for Caregiving Act (S. 3109 118th Congress) Credit for Caring Act of 2025 (S. 925/H.R. 2036) Lifespan Respite Care Reauthorization Act (S.830/H.R.2560) DeOndra Dixon Investigation of Co-occurring Conditions across the Lifespan to Understand Down Syndrome (INCLUDE) Project Act of 2025 (H.R. 3491/S. 1838) Paid Family and Medical Leave Tax Credit Extension and Enhancement Act (S. 400/H.R. 996) Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025 (S. 2016/H.R. 4189 118th Congress; S. 1261/H.R. 4206 119th Congress) PACE Part D Choice Act (S. 1703/H.R. 3549 118th Congress) Improving Seniors' Timely Access to Care Act of 2025 (S. 1816/H.R. 3514 119th Congress) Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research and Innovation in Neurological Science (HEALTHY BRAINS) Act of 2026 (H.R. 7779 119th Congress) Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act of 2023(S. 526/H.R. 1092) Essential Caregivers Act (H.R. 6766 119th Congress) Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717/H.R. 5343 119th Congress) The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S.2761/H.R.5269) Linking Seniors to Needed Legal Services Act (H.R. 8588, 118th Congress) Amending the Rules of the House of Representatives to establish a Permanent Select Committee on Aging (H. Res. 1029) Catching Up Family Caregivers Act (S. 5149 / H.R. 9764, 118th Congress) Improving Retirement Security for Family Caregivers Act (S. 5148 / H.R. 9765, 118th Congress) Charitable Act (S. 317/H.R. 801) Alzheimers Law Enforcement Education Act of 2025 (H.R. 3389) Health Tech Investment Act (S.1399) One Big Beautiful Bill Act (H.R. 1) Older Americans Act Reauthorization Act of 2025 (S. 2120) Lowering Costs for Caregivers Act of 2025 (S. 1565 / H.R. 138) Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S. 2761 / H.R. 5269) Alzheimers Screening and Prevention Act (H.R. 6130/S. 3267) Other matters related to disaster preparedness and older adults, public health emergencies, public health preparedness and response, telehealth, health disparities, and older Americans/people with disabilities in all phases of emergencies Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease Other matters related to care payment models, including the GUIDE model Other matters related to Medicare care planning code 99483 Other matters related to health care workforce shortages Other matters related to home- and community-based services Other matters related to disaster preparedness and older adults Other matters related to Social Security Other matters related to technology-enabled collaborative learning and capacity-building models (Project ECHO) Other matters related to beta-amyloid PET scans Other matters related to selected diagnoses and services rendered under ICD-10 Other matters related to caregiving Other matters related to medical devices Other matters related to rural health Other matters related to veterans' health and traumatic brain injury (TBI) Other matters related to Tricare Other matters related to research Other matters related to biomarkers including blood based tests and cerebral spinal fluid (CSF) Other matters related to public health Other matters related to elder justice, abuse and neglect Other matters related to Medicaid Other matters related to nonprofit infrastructure and operations Other matters related to the National Plan to Address Alzheimer's Disease and the NAPA Advisory Council Other matters related to the Alzheimer's Screening and Prevention (ASAP) Act Other matters related to brain health, risk reduction, and the U.S. POINTER study and results Other matters related to biomarker disclosure and discrimination (Office of Civil Rights at HHS) Other matters related to long-term care","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55648,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"CONANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67551,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140279,"prefix":"ms","prefix_display":"MS.","first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114396,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"HEATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141524,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARY","nickname":null,"middle_name":"AGNES","last_name":"GERMILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"OSUNA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145183,"prefix":null,"prefix_display":null,"first_name":"ZOE","nickname":null,"middle_name":null,"last_name":"SALZBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152388,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"WING","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":56,"name":"Federal Emergency Management Agency (FEMA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":5,"name":"Government Accountability Office (GAO)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":138,"name":"Indian Health Service"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":91,"name":"Social Security Administration (SSA)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Matters related to Fiscal Years 2026 and 2027 appropriations for Alzheimers funding at the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, Health Resources and Services Administration, Administration for Community Living, Department of Defense, and Indian Health Service Matters related to Fiscal Year 2026 and 2027 appropriations language reflecting scientific advances in Alzheimers at the Food and Drug Administration and the Centers for Medicare & Medicaid Services Appropriations related to OAA Title III-C Nutrition Program and appropriations related to [88 FR 80085] Initiative on Women's Health Research Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease Other matters related to beta-amyloid PET scans Other matters related to diagnostics for Alzheimers disease and other dementia Other matters related to brain health and risk reduction Other matters related to clinical trials","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55648,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"CONANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140279,"prefix":"ms","prefix_display":"MS.","first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67551,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141524,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARY","nickname":null,"middle_name":"AGNES","last_name":"GERMILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"OSUNA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145183,"prefix":null,"prefix_display":null,"first_name":"ZOE","nickname":null,"middle_name":null,"last_name":"SALZBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152388,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"WING","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/add69aea-522e-41c8-b0fb-26c956017d4c/","filing_uuid":"add69aea-522e-41c8-b0fb-26c956017d4c","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/add69aea-522e-41c8-b0fb-26c956017d4c/print/","filing_document_content_type":"text/html","income":null,"expenses":"464268.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Emma Peters","dt_posted":"2026-04-20T15:59:26-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"200 Massachusetts Ave NW","registrant_address_2":"Suite 520","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":21687,"url":"https://lda.gov/api/v1/registrants/21687/","house_registrant_id":34546,"name":"NATIONAL VENTURE CAPITAL ASSOCIATION","description":"professional associatin for the venture capital industry","address_1":"200 Massachusetts Ave NW","address_2":"Suite 520","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHELE SOLOMON","contact_telephone":"+1 202-864-5924","dt_updated":"2026-07-30T09:15:35.570629-04:00"},"client":{"id":128604,"url":"https://lda.gov/api/v1/clients/128604/","client_id":12,"name":"NATIONAL VENTURE CAPITAL ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-10-01"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"S. 445, The Carried Interest Fairness Act of 2025; H.R. 1091, The Carried Interest Fairness Act; S. 695, The Small Business Investment Act of 2025; H.R. 1199, The Small Business Investment Act of 2025; S. 866, The American Innovation and Jobs Act of 2025; H.R. 1990, The American Innovation and R&D Competitiveness Act of 2025; H.R. 1, The One Big Beautiful Bill Act of 2025; Public Law No. 115-97 (The Tax Cuts and Jobs Act); Energy Tax Credits included in Public Law No. 117-169 (The Inflation Reduction Act).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BAN","general_issue_code_display":"Banking","description":"Regulation D and exempt offering framework; Emerging growth company and small cap company capital formation issues; Initial public offering and public company reporting issues; Venture Capital fund definition and private fund compliance issues; Blockchain regulatory and policy issues; Digital Asset Market Clarity (CLARITY) Act (H.R. 3633), GENIUS Act of2025 (S.394), and STABLE Act of2025 (H.R.2392); capital formation and JOBS Act modernization; Developing and Empowering our Aspiring Leaders (DEAL) Act; Improving Capital Allocation for Newcomers (ICAN) Act; INVEST Act; Implementation of the Foreign Investment Risk Review Modernization Act; foreign outbound investment restrictions; FinCEN rule on Anti-Money Laundering/Countering the Financing of Terrorism Program and Suspicious Activity Report Filing Requirements for Registered Investment Advisers and Exempt Reporting Advisers.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":235,"name":"Financial Crimes Enforcement Network (FinCEN)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":88,"name":"Securities & Exchange Commission (SEC)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Creation of a Startup Visa; International Entrepreneur Rule; H-1B Visas.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"ENG","general_issue_code_display":"Energy/Nuclear","description":"Energy tax credits included in H.R.l, The One Big Beautiful Bill Act; H.R. 4776, the Standardizing Permitting and Expediting Economic Development Act (SPEED Act). Energy permitting reform; ARPA-E.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":33,"name":"Energy, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; streamlining the FDA approval process, implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; federal research funding, Advanced Research Project Agency- Health. AI in healthcare.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Intellectual property issues that impact startups.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":219,"name":"Natl Institute of Standards & Technology (NIST)"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Basic research funding and technology commercialization issues; Artificial Intelligence policy issues, including implementation of the U.S. AI Action Plan; CREATE AI Act H.R.2385; investment in critical technology areas.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":33,"name":"Energy, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":76,"name":"Natl Science Foundation (NSF)"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"}]},{"general_issue_code":"SMB","general_issue_code_display":"Small Business","description":"SBIR/STTR reauthorization; the SBIC accrual debenture license","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Antitrust and competition policy impacting startups; FTC rulemaking on Hart-Scott-Rodino premerger notification program; FTC-DOJ Merger Guidelines","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":76,"name":"Natl Science Foundation (NSF)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Monitor updated export control regulations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to procurement through the Department of Defense; issues related to private capital and procurement as it relates to the FY2026 National Defense Authorization Act (NDAA).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"AGR","general_issue_code_display":"Agriculture","description":"Blockchain regulatory and policy issues; Digital Asset Market Clarity (CLARITY) Act (H.R. 3633), GENIUS Act of 2025 (S.394), and STABLE Act of 2025 (H.R.2392)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":45,"name":"Commodity Futures Trading Commission (CFTC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/086ec4d3-ca27-4e10-a377-904a48c10338/","filing_uuid":"086ec4d3-ca27-4e10-a377-904a48c10338","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/086ec4d3-ca27-4e10-a377-904a48c10338/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Kenneth E Swab","dt_posted":"2026-07-20T11:44:24-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"301 South Bronough Street","registrant_address_2":"Suite 600","registrant_different_address":false,"registrant_city":"Tallahassee","registrant_state":"FL","registrant_zip":"32301","registrant":{"id":401053970,"url":"https://lda.gov/api/v1/registrants/401053970/","house_registrant_id":null,"name":"GRAYROBINSON PA","description":"Law firm.","address_1":"301 South Bronough Street","address_2":"Suite 600","address_3":null,"address_4":null,"city":"Tallahassee","state":"FL","state_display":"Florida","zip":"32301","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KENNETH SWAB","contact_telephone":"+1 202-546-1761","dt_updated":"2026-07-28T11:59:14.995253-04:00"},"client":{"id":197355,"url":"https://lda.gov/api/v1/clients/197355/","client_id":75,"name":"ANGEL CAPITAL ASSOCIATION","general_description":"Private investor and angel group trade association.","client_government_entity":false,"client_self_select":null,"state":"KS","state_display":"Kansas","country":"US","country_display":"United States of America","ppb_state":"KS","ppb_state_display":"Kansas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-02-01"},"lobbying_activities":[{"general_issue_code":"FIN","general_issue_code_display":"Financial Institutions/Investments/Securities","description":"Implementation of SEC's expanded accredited investor definition. H.R.3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025 (INVEST Act), all provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71392,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"MCCANNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":94084,"prefix":null,"prefix_display":null,"first_name":"BLAIR","nickname":null,"middle_name":null,"last_name":"HANCOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":88,"name":"Securities & Exchange Commission (SEC)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Promotion of angel investment tax credits and exemptions. Promotion of public policy promoting angel capital investments. Implementation of Opportunity Zones. Issues related to carried interest. Issues related to IRC section 1202, Small Business Stock Gains Exclusion. S. 695, Small Business Investment Act of 2025, all provisions. H.R. 1199, Small Business Investment Act of 2025, all provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71392,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"MCCANNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":94084,"prefix":null,"prefix_display":null,"first_name":"BLAIR","nickname":null,"middle_name":null,"last_name":"HANCOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":88,"name":"Securities & Exchange Commission (SEC)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/82d0e925-8f96-4e10-bb9b-ced64071378f/","filing_uuid":"82d0e925-8f96-4e10-bb9b-ced64071378f","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/82d0e925-8f96-4e10-bb9b-ced64071378f/print/","filing_document_content_type":"text/html","income":null,"expenses":"1800000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Robert Egge","dt_posted":"2026-07-20T12:42:58-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th Street, NW","registrant_address_2":"Suite 500","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":1262,"url":"https://lda.gov/api/v1/registrants/1262/","house_registrant_id":30526,"name":"ALZHEIMER'S ASSOCIATION","description":null,"address_1":"655 15th Street, NW","address_2":"Suite 500","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROBERT EGGE","contact_telephone":"+1 202-638-8660","dt_updated":"2026-07-30T10:03:36.870640-04:00"},"client":{"id":102599,"url":"https://lda.gov/api/v1/clients/102599/","client_id":12,"name":"ALZHEIMER'S ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"NAPA Reauthorization Act (P.L. 118-92) Alzheimers Accountability and Investment Act (P.L. 118-93) Comprehensive Care for Alzheimers Act (S. 626/H.R. 1637 118th Congress) Reauthorization of the BOLD Infrastructure for Alzheimer's Act (P.L. 115-406) BOLD Reauthorization Act (P.L. 118-142) Accelerating Access to Dementia & Alzheimers Provider Training (AADAPT) Act (H.R. 3747 / S. 4036) The Senator Elizabeth Dole 21st Century Veterans Healthcare and Benefits Improvement Act (P.L. 118-210) VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act of 2023 (S. 10 118th Congress) Access to Innovative Treatments Act of 2026 (H.R. 9418) Mandating Exclusive Review of Individual Treatments (MERIT) Act of 2023 (H.R. 133 118th Congress) Elder Justice Reauthorization and Modernization Act of 2026 (H.R. 8060) Expanding Veterans Options for Long-Term Care Act (S. 495/H.R.1815 118th Congress) Palliative Care and Hospice Education and Training Act of 2023 (S. 2287/H.R. 4425) Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 (S. 1544/H.R. 1199 118th Congress) Supporting Our Seniors Act (S. 2762) Alleviating Barriers for Caregiving Act (S. 1227/H.R. 2491) Credit for Caring Act (S. 925/H.R. 2036) Lifespan Respite Care Reauthorization Act (S.830/H.R.2560) DeOndra Dixon INCLUDE Project Act of 2025 (H.R. 3491/S. 1838) Paid Family and Medical Leave Tax Credit Extension and Enhancement Act (S. 400/H.R. 996) Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act (S. 1261/H.R. 4206) PACE Part D Choice Act (S. 1703/H.R. 3549 118th Congress) Improving Seniors' Access to Timely Care Act of 2025 (S. 1816/H.R. 3514) Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research and Innovation in Neurological Science (HEALTHY BRAINS) Act (H.R. 7779) Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act of 2023(S. 526/H.R. 1092) Essential Caregivers Act (H.R. 6766) Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717/H.R. 5343) The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S.2761/H.R.5269) Linking Seniors to Needed Legal Services Act (H.R. 6728) Amending the Rules of the House of Representatives to establish a Permanent Select Committee on Aging (H. Res. 1013) Catching Up Family Caregivers Act of 2026 (S. 4291/H.R. 8273) Improving Retirement Security for Family Caregivers Act of 2026 (S. 4291 /H.R. 8273) Charitable Act (S. 317/H.R. 801) Alzheimers Law Enforcement Education Act of 2025 (H.R. 3389) Health Tech Investment Act (S.1399) One Big Beautiful Bill Act (H.R. 1) Older Americans Act Reauthorization Act of 2025 (S. 2120) Lowering Costs for Caregivers Act of 2025 (S. 1565/H.R. 138) Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S. 2761 / H.R. 5269) Enhanced Alerts for Missing Loved Ones with Disabilities Act of 2026 (S. 4670/H.R. 9118) Alzheimers Screening and Prevention Act (H.R. 6130/S. 3267) Other matters related to disaster preparedness and older adults, public health emergencies, public health preparedness and response, telehealth, health disparities, and older Americans/people with disabilities in all phases of emergencies Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease Other matters related to care payment models, including the GUIDE model Other matters related to Medicare care planning code 99483 Other matters related to health care workforce shortages Other matters related to home- and community-based services Other matters related to disaster preparedness and older adults Other matters related to Social Security Other matters related to technology-enabled collaborative learning and capacity-building models (Project ECHO) Other matters related to beta-amyloid PET scans Other matters related to selected diagnoses and services rendered under ICD-10 Other matters related to caregiving Other matters related to medical devices Other matters related to rural health Other matters related to veterans' health and traumatic brain injury (TBI) Other matters related to Tricare Other matters related to research Other matters related to biomarkers including blood-based tests and cerebral spinal fluid (CSF) Other matters related to public health Other matters related to elder justice, abuse and neglect Other matters related to Medicaid Other matters related to nonprofit infrastructure and operations Other matters related to the National Plan to Address Alzheimer's Disease and the NAPA Advisory Council Other matters related to the Alzheimer's Screening and Prevention (ASAP) Act Other matters related to the reauthorization of the Alzheimers semipostal stamp Other matters related to brain health, risk reduction, and the U.S. POINTER study and results Other matters related to biomarker disclosure and discrimination (Office of Civil Rights at HHS) Other matters related to long-term care","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55648,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"CONANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67551,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140279,"prefix":"ms","prefix_display":"MS.","first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114396,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"HEATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141524,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARY","nickname":null,"middle_name":"AGNES","last_name":"GERMILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"OSUNA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145183,"prefix":null,"prefix_display":null,"first_name":"ZOE","nickname":null,"middle_name":null,"last_name":"SALZBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152388,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"WING","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":56,"name":"Federal Emergency Management Agency (FEMA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":5,"name":"Government Accountability Office (GAO)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":138,"name":"Indian Health Service"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":91,"name":"Social Security Administration (SSA)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Matters related to Fiscal Years 2026 and 2027 appropriations for Alzheimers funding at the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, Health Resources and Services Administration, Administration for Community Living, Department of Defense, and Indian Health Service Matters related to Fiscal Year 2026 and 2027 appropriations language reflecting scientific advances in Alzheimers at the Food and Drug Administration and the Centers for Medicare & Medicaid Services Appropriations related to OAA Title III-C Nutrition Program and appropriations related to [88 FR 80085] Initiative on Women's Health Research Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease Other matters related to beta-amyloid PET scans Other matters related to diagnostics for Alzheimers disease and other dementia Other matters related to brain health and risk reduction Other matters related to clinical trials","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55648,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"CONANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140279,"prefix":"ms","prefix_display":"MS.","first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67551,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141524,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARY","nickname":null,"middle_name":"AGNES","last_name":"GERMILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"OSUNA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145183,"prefix":null,"prefix_display":null,"first_name":"ZOE","nickname":null,"middle_name":null,"last_name":"SALZBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152388,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"WING","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[{"name":"ALZHEIMERS IMPACT MOVEMENT (AIM)","url":"https://alzimpact.org","address_1":"655 15th Street, NW, Ste. 500","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_city":null,"ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America"}]},{"url":"https://lda.gov/api/v1/filings/8d05c44b-9fa3-46e4-8b11-c0c2f7b5acae/","filing_uuid":"8d05c44b-9fa3-46e4-8b11-c0c2f7b5acae","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/8d05c44b-9fa3-46e4-8b11-c0c2f7b5acae/print/","filing_document_content_type":"text/html","income":null,"expenses":"1173637.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Emma Peters","dt_posted":"2026-07-20T17:54:47-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"200 Massachusetts Ave NW","registrant_address_2":"Suite 520","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":21687,"url":"https://lda.gov/api/v1/registrants/21687/","house_registrant_id":34546,"name":"NATIONAL VENTURE CAPITAL ASSOCIATION","description":"professional associatin for the venture capital industry","address_1":"200 Massachusetts Ave NW","address_2":"Suite 520","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHELE SOLOMON","contact_telephone":"+1 202-864-5924","dt_updated":"2026-07-30T09:15:35.570629-04:00"},"client":{"id":128604,"url":"https://lda.gov/api/v1/clients/128604/","client_id":12,"name":"NATIONAL VENTURE CAPITAL ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-10-01"},"lobbying_activities":[{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Antitrust and competition policy impacting startups; FTC rulemaking on Hart-Scott-Rodino premerger notification program; FTC-DOJ Merger Guidelines","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":76,"name":"Natl Science Foundation (NSF)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Monitor updated export control regulations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to procurement through the Department of Defense; issues related to private capital and procurement as it relates to the FY2027 National Defense Authorization Act (NDAA).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"AGR","general_issue_code_display":"Agriculture","description":"Blockchain regulatory and policy issues; Digital Asset Market Clarity (CLARITY) Act (H.R. 3633), GENIUS Act of 2025 (S.394), and STABLE Act of 2025 (H.R.2392)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":45,"name":"Commodity Futures Trading Commission (CFTC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"S. 445, The Carried Interest Fairness Act of 2025; H.R. 1091, The Carried Interest Fairness Act; S. 695, The Small Business Investment Act of 2025; H.R. 1199, The Small Business Investment Act of 2025; S. 866, The American Innovation and Jobs Act of 2025; H.R. 1990, The American Innovation and R&D Competitiveness Act of 2025; H.R. 1, The One Big Beautiful Bill Act of 2025; Public Law No. 115-97 (The Tax Cuts and Jobs Act); Energy Tax Credits included in Public Law No. 117-169 (The Inflation Reduction Act).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BAN","general_issue_code_display":"Banking","description":"Regulation D and exempt offering framework; Emerging growth company and small cap company capital formation issues; Initial public offering and public company reporting issues; Venture Capital fund definition and private fund compliance issues; Blockchain regulatory and policy issues; Digital Asset Market Clarity (CLARITY) Act (H.R. 3633), GENIUS Act of 2025 (S.394), and STABLE Act of 2025 (H.R.2392); JOBS Act modernization; Developing and Empowering our Aspiring Leaders (DEAL) Act; Improving Capital Allocation for Newcomers (ICAN) Act; INVEST Act; Implementation of the Foreign Investment Risk Review Modernization Act; foreign outbound investment restrictions; FinCEN rule on Anti-Money Laundering/Countering the Financing of Terrorism Program and Suspicious Activity Report Filing Requirements for Registered Investment Advisers and Exempt Reporting Advisers.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":235,"name":"Financial Crimes Enforcement Network (FinCEN)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":88,"name":"Securities & Exchange Commission (SEC)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Creation of a Startup Visa; International Entrepreneur Rule; H-1B Visas.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"ENG","general_issue_code_display":"Energy/Nuclear","description":"Energy tax credits included in H.R.l, The One Big Beautiful Bill Act; H.R. 4776, the Standardizing Permitting and Expediting Economic Development Act (SPEED Act). Energy permitting reform; ARPA-E.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":33,"name":"Energy, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; streamlining the FDA approval process, implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; federal research funding, Advanced Research Project Agency- Health; AI in healthcare; The Ensuring Patient Access to Critical Breakthrough Products Act; RAPID Coverage Pathway","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Intellectual property issues that impact startups.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":219,"name":"Natl Institute of Standards & Technology (NIST)"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Basic research funding and technology commercialization issues; Artificial Intelligence policy issues, including implementation of the U.S. AI Action Plan; CREATE AI Act H.R.2385; investment in critical technology areas.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":33,"name":"Energy, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":76,"name":"Natl Science Foundation (NSF)"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"}]},{"general_issue_code":"SMB","general_issue_code_display":"Small Business","description":"SBIR/STTR reauthorization; the SBIC accrual debenture license","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148648,"prefix":"mrs","prefix_display":"MRS.","first_name":"CAROLINE","nickname":null,"middle_name":"MOODY","last_name":"SCHELLHAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149545,"prefix":null,"prefix_display":null,"first_name":"DIEM-MI","nickname":null,"middle_name":null,"last_name":"LU","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3ffc8f0e-b125-4120-9c98-5bdbe847a2b4/","filing_uuid":"3ffc8f0e-b125-4120-9c98-5bdbe847a2b4","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/3ffc8f0e-b125-4120-9c98-5bdbe847a2b4/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Kenneth E Swab","dt_posted":"2026-10-20T10:59:48-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"301 South Bronough Street","registrant_address_2":"Suite 600","registrant_different_address":false,"registrant_city":"Tallahassee","registrant_state":"FL","registrant_zip":"32301","registrant":{"id":401053970,"url":"https://lda.gov/api/v1/registrants/401053970/","house_registrant_id":null,"name":"GRAYROBINSON PA","description":"Law firm.","address_1":"301 South Bronough Street","address_2":"Suite 600","address_3":null,"address_4":null,"city":"Tallahassee","state":"FL","state_display":"Florida","zip":"32301","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KENNETH SWAB","contact_telephone":"+1 202-546-1761","dt_updated":"2026-07-28T11:59:14.995253-04:00"},"client":{"id":197355,"url":"https://lda.gov/api/v1/clients/197355/","client_id":75,"name":"ANGEL CAPITAL ASSOCIATION","general_description":"Private investor and angel group trade association.","client_government_entity":false,"client_self_select":null,"state":"KS","state_display":"Kansas","country":"US","country_display":"United States of America","ppb_state":"KS","ppb_state_display":"Kansas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-02-01"},"lobbying_activities":[{"general_issue_code":"FIN","general_issue_code_display":"Financial Institutions/Investments/Securities","description":"Implementation of SEC's expanded accredited investor definition. H.R.3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025 (INVEST Act), all provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71392,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"MCCANNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":94084,"prefix":null,"prefix_display":null,"first_name":"BLAIR","nickname":null,"middle_name":null,"last_name":"HANCOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":88,"name":"Securities & Exchange Commission (SEC)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Promotion of angel investment tax credits and exemptions. Promotion of public policy promoting angel capital investments. Implementation of Opportunity Zones. Issues related to carried interest. Issues related to IRC section 1202, Small Business Stock Gains Exclusion. S. 695, Small Business Investment Act of 2025, all provisions. H.R. 1199, Small Business Investment Act of 2025, all provisions. H.R. 1, One Big Beautiful Bill Act, provisions affecting investments.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71392,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"MCCANNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":94084,"prefix":null,"prefix_display":null,"first_name":"BLAIR","nickname":null,"middle_name":null,"last_name":"HANCOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":88,"name":"Securities & Exchange Commission (SEC)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/ef82bcc8-b23f-411e-b25c-ed9d2899214f/","filing_uuid":"ef82bcc8-b23f-411e-b25c-ed9d2899214f","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/ef82bcc8-b23f-411e-b25c-ed9d2899214f/print/","filing_document_content_type":"text/html","income":null,"expenses":"1400000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Robert Egge","dt_posted":"2026-10-20T11:04:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th Street, NW","registrant_address_2":"Suite 500","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":1262,"url":"https://lda.gov/api/v1/registrants/1262/","house_registrant_id":30526,"name":"ALZHEIMER'S ASSOCIATION","description":null,"address_1":"655 15th Street, NW","address_2":"Suite 500","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROBERT EGGE","contact_telephone":"+1 202-638-8660","dt_updated":"2026-07-30T10:03:36.870640-04:00"},"client":{"id":102599,"url":"https://lda.gov/api/v1/clients/102599/","client_id":12,"name":"ALZHEIMER'S ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"NAPA Reauthorization Act (P.L. 118-92) Alzheimers Accountability and Investment Act (P.L. 118-93) Comprehensive Care for Alzheimers Act (S. 626 / H.R. 1637 118th Congress) Reauthorization of the BOLD Infrastructure for Alzheimer's Act (P.L. 115-406) BOLD Reauthorization Act (P.L. 118-142) Accelerating Access to Dementia & Alzheimers Provider Training (AADAPT) Act (H.R. 3747 / S. 4036) The Senator Elizabeth Dole 21st Century Veterans Healthcare and Benefits Improvement Act (P.L. 118-210) VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act of 2023 (S. 10 118th Congress) Access to Innovative Treatments Act of 2026 (H.R. 9418) Mandating Exclusive Review of Individual Treatments (MERIT) Act of 2023 (H.R. 133 118th Congress) Elder Justice Reauthorization and Modernization Act of 2023 (S. 1198/H.R. 2718 118th Congress) Expanding Veterans Options for Long-Term Care Act (S. 495/H.R.1815 118th Congress) Palliative Care and Hospice Education and Training Act (S. 2287/H.R. 4425) Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 (S. 1544/H.R. 1199 118th Congress) Supporting Our Seniors Act (S. 2762) Alleviating Barriers for Caregiving Act (S. 3109 118th Congress) Credit for Caring Act (S. 925/H.R. 2036) Lifespan Respite Care Reauthorization Act of 2025 (S.830/H.R.2560) DeOndra Dixon Investigation of Co-occurring Conditions across the Lifespan to Understand Down Syndrome (INCLUDE) Project Act of 2026 (H.R. 3491/S. 1838) Paid Family and Medical Leave Tax Credit Extension and Enhancement Act (S. 400/H.R. 996) Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025 (S. 1261/H.R. 4206) PACE Part D Choice Act (S. 1703/H.R. 3549 118th Congress) Improving Seniors' Access to Timely Care Act of 2025 (S. 1816/H.R. 3514) Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research And Innovation in Neurological Science (HEALTHY BRAINS) Act of 2026 (H.R. 7779) Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act of 2023 (S. 526/H.R. 1092 118th Congress) Essential Caregivers Act of 2025 (H.R. 6766) Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717/H.R. 5343) Linking Seniors to Needed Legal Services Act of 2025 (H.R. 6728) Amending the Rules of the House of Representatives to establish a Permanent Select Committee on Aging (H. Res. 1029 118th Congress) Catching Up Family Caregivers Act (S. 4291 / H.R. 8273) Improving Retirement Security for Family Caregivers Act (S. 4292 / H.R. 8274) Charitable Act (S. 317/H.R. 801) Alzheimers Law Enforcement Education Act (H.R. 3389) Health Tech Investment Act (S.1399) One Big Beautiful Bill Act (H.R. 1) Older Americans Act Reauthorization Act of 2025 (S. 2120) Lowering Costs for Caregivers Act of 2025 (S. 1565 / H.R. 138) Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S. 2761 / H.R. 5269) Enhanced Alerts for Missing Loved Ones with Disabilities Act of 2026 (S. 4670 / H.R. 9118) Alzheimers Screening and Prevention Act (H.R. 6130/S. 3267) Other matters related to disaster preparedness and older adults, public health emergencies, public health preparedness and response, telehealth, health disparities, and older Americans/people with disabilities in all phases of emergencies Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease Other matters related to care payment models, including the GUIDE model Other matters related to Medicare care planning code 99483 Other matters related to health care workforce shortages Other matters related to home- and community-based services Other matters related to disaster preparedness and older adults Other matters related to Social Security Other matters related to technology-enabled collaborative learning and capacity-building models (Project ECHO) Other matters related to beta-amyloid PET scans Other matters related to selected diagnoses and services rendered under ICD-10 Other matters related to caregiving Other matters related to medical devices Other matters related to rural health Other matters related to veterans' health and traumatic brain injury (TBI) Other matters related to Tricare Other matters related to research Other matters related to biomarkers including blood-based tests and cerebral spinal fluid (CSF) Other matters related to public health Other matters related to elder justice, abuse and neglect Other matters related to Medicaid Other matters related to nonprofit infrastructure and operations Other matters related to the National Plan to Address Alzheimer's Disease and the NAPA Advisory Council Other matters related to the Alzheimer's Screening and Prevention (ASAP) Act Other matters related to the reauthorization of the Alzheimers semipostal stamp Other matters related to brain health, risk reduction, and the U.S. POINTER study and results Other matters related to biomarker disclosure and discrimination (Office of Civil Rights at HHS) Other matters related to long-term care Other matters related to drug development","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55648,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"CONANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67551,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140279,"prefix":"ms","prefix_display":"MS.","first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114396,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"HEATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141524,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARY","nickname":null,"middle_name":"AGNES","last_name":"GERMILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"OSUNA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145183,"prefix":null,"prefix_display":null,"first_name":"ZOE","nickname":null,"middle_name":null,"last_name":"SALZBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152388,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"WING","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":56,"name":"Federal Emergency Management Agency (FEMA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":5,"name":"Government Accountability Office (GAO)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":138,"name":"Indian Health Service"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":91,"name":"Social Security Administration (SSA)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Matters related to Fiscal Years 2026 and 2027 appropriations for Alzheimers funding at the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, Health Resources and Services Administration, Administration for Community Living, Department of Defense, and Indian Health Service Matters related to Fiscal Year 2026 and 2027 appropriations language reflecting scientific advances in Alzheimers at the Food and Drug Administration and the Centers for Medicare & Medicaid Services Appropriations related to OAA Title III-C Nutrition Program and appropriations related to [88 FR 80085] Initiative on Women's Health Research Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease Other matters related to beta-amyloid PET scans Other matters related to diagnostics for Alzheimers disease and other dementia Other matters related to brain health and risk reduction Other matters related to clinical trials","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55648,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"CONANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140279,"prefix":"ms","prefix_display":"MS.","first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67551,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141524,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARY","nickname":null,"middle_name":"AGNES","last_name":"GERMILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"OSUNA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145183,"prefix":null,"prefix_display":null,"first_name":"ZOE","nickname":null,"middle_name":null,"last_name":"SALZBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152388,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"WING","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/175fb0a5-185d-478f-99fa-93c219330db8/","filing_uuid":"175fb0a5-185d-478f-99fa-93c219330db8","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/175fb0a5-185d-478f-99fa-93c219330db8/print/","filing_document_content_type":"text/html","income":null,"expenses":"671823.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Emma Peters","dt_posted":"2026-10-20T14:32:09-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"200 Massachusetts Ave NW","registrant_address_2":"Suite 520","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":21687,"url":"https://lda.gov/api/v1/registrants/21687/","house_registrant_id":34546,"name":"NATIONAL VENTURE CAPITAL ASSOCIATION","description":"professional associatin for the venture capital industry","address_1":"200 Massachusetts Ave NW","address_2":"Suite 520","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHELE SOLOMON","contact_telephone":"+1 202-864-5924","dt_updated":"2026-07-30T09:15:35.570629-04:00"},"client":{"id":128604,"url":"https://lda.gov/api/v1/clients/128604/","client_id":12,"name":"NATIONAL VENTURE CAPITAL ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-10-01"},"lobbying_activities":[{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Creation of a Startup Visa; International Entrepreneur Rule; H-1B Visas; OPT and STEM OPT Extention.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":251,"name":"U.S. Immigration & Customs Enforcement (ICE)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"S. 445, The Carried Interest Fairness Act of 2025; H.R. 1091, The Carried Interest Fairness Act; S. 695, The Small Business Investment Act of 2025; H.R. 1199, The Small Business Investment Act of 2025; S. 866, The American Innovation and Jobs Act of 2025; H.R. 1990, The American Innovation and R&D Competitiveness Act of 2025; Implementation of H.R. 1, The One Big Beautiful Bill Act of 2025; Public Law No. 115-97 (The Tax Cuts and Jobs Act); Energy Tax Credits included in Public Law No. 117-169 (The Inflation Reduction Act); Qualified Small Business Stock (QSBS) under Internal Revenue Code Section 1202; digital asset taxation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BAN","general_issue_code_display":"Banking","description":"Regulation D and exempt offering framework; Emerging growth company and small cap company capital formation issues; Initial public offering and public company reporting issues; Venture Capital fund definition and private fund compliance issues; Blockchain regulatory and policy issues; Digital Asset Market Clarity (CLARITY) Act (H.R. 3633), GENIUS Act of 2025 (S.394), and STABLE Act of 2025 (H.R.2392); JOBS Act modernization; Developing and Empowering our Aspiring Leaders (DEAL) Act; Improving Capital Allocation for Newcomers (ICAN) Act; S. 2906, Expanding American Entrepreneurship Act; INVEST Act; Implementation of the Foreign Investment Risk Review Modernization Act; foreign outbound investment restrictions; FinCEN rule on Anti-Money Laundering/Countering the Financing of Terrorism Program and Suspicious Activity Report Filing Requirements for Registered Investment Advisers and Exempt Reporting Advisers; continuation vehicles.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":235,"name":"Financial Crimes Enforcement Network (FinCEN)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":88,"name":"Securities & Exchange Commission (SEC)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"ENG","general_issue_code_display":"Energy/Nuclear","description":"Energy tax credits included in H.R.l, The One Big Beautiful Bill Act; H.R. 4776, the Standardizing Permitting and Expediting Economic Development Act (SPEED Act). Energy permitting reform; ARPA-E.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":33,"name":"Energy, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; streamlining the FDA approval process, implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; federal research funding, Advanced Research Project Agency- Health; AI in healthcare; The Ensuring Patient Access to Critical Breakthrough Products Act; RAPID Coverage Pathway; ARPA-H.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Intellectual property issues that impact startups.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":219,"name":"Natl Institute of Standards & Technology (NIST)"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Basic research funding and technology commercialization issues; Artificial Intelligence policy issues, including implementation of the U.S. AI Action Plan; investment in critical technology areas; federal research funding and grant administration policies affecting startups, universities, and technology commercialization, including OMB proposed Regulation for Federal Financial Assistance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":33,"name":"Energy, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":76,"name":"Natl Science Foundation (NSF)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"}]},{"general_issue_code":"SMB","general_issue_code_display":"Small Business","description":"SBIR/STTR reauthorization; the SBIC accrual debenture license.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Antitrust and competition policy impacting startups; FTC rulemaking on Hart-Scott-Rodino premerger notification program; FTC-DOJ Merger Guidelines","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":76,"name":"Natl Science Foundation (NSF)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Monitor updated export control regulations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to procurement through the Department of Defense; issues related to private capital and procurement as it relates to the FY2027 National Defense Authorization Act (NDAA).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"AGR","general_issue_code_display":"Agriculture","description":"Blockchain regulatory and policy issues; Digital Asset Market Clarity (CLARITY) Act (H.R. 3633), GENIUS Act of 2025 (S.394), and STABLE Act of 2025 (H.R.2392)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59391,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"FRANKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145115,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145116,"prefix":null,"prefix_display":null,"first_name":"ASHLYN","nickname":null,"middle_name":null,"last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":45,"name":"Commodity Futures Trading Commission (CFTC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}